| 1 |
Zanon-Zotin MC, Sveikata L, Viswanathan A, et al.Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management [J].Curr Opin Neurol, 2021, 34(2): 246-257.
|
| 2 |
Markus HS, de Leeuw FE.Cerebral small vessel disease: recent advances and future directions [J].Int J Stroke, 2023, 18(1): 4-14.
|
| 3 |
Wardlaw JM, Smith C, Dichgans M.Small vessel disease: mechanisms and clinical implications [J].Lancet Neurol, 2019, 18(7): 684-696.
|
| 4 |
Liu Y, Dong YH, Lyu PY, et al.Hypertension-induced cerebral small vessel disease leading to cognitive impairment [J].Chin Med J (Engl) ,2018, 131(5): 615-619.
|
| 5 |
Gao Y, Li D, Lin J, et al.Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets [J].Front Aging Neurosci, 2022, 14: 961661.
|
| 6 |
Dichgans M, Leys D.Vascular Cognitive Impairment [J].Circ Res,2017, 120(3): 573-591.
|
| 7 |
Teng Z, Dong Y, Zhang D, et al.Cerebral small vessel disease and post-stroke cognitive impairment [J].Int J Neurosci, 2017, 127(9):824-830.
|
| 8 |
Evans LE, Taylor JL, Smith CJ, et al.Cardiovascular comorbidities,inflammation, and cerebral small vessel disease [J].Cardiovasc Res,2021, 117(13): 2575-2588.
|
| 9 |
Tian Y, Zhao M, Chen Y, et al.The underlying role of the glymphatic system and meningeal lymphatic vessels in cerebral small vessel disease [J].Biomolecules, 2022, 12(6): 748.
|
| 10 |
Pasi M, Sugita L, Xiong L, et al.Association of cerebral small vessel disease and cognitive decline after intracerebral hemorrhage [J].Neurology, 2021, 96(2): e182-e192.
|
| 11 |
Tang J, Zhang M, Liu N, et al.The association between glymphatic system dysfunction and cognitive impairment in cerebral small vessel disease [J].Front Aging Neurosci, 2022, 14: 916633.
|
| 12 |
Wardlaw JM, Debette S, Jokinen H, et al.ESO Guideline on covert cerebral small vessel disease [J].Eur Stroke J, 2021, 6(2): CXICLXII.
|
| 13 |
Georgakis MK, Fang R, During M, et al.Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: a multicenter prospective cohort study [J].Alzheimers Dement, 2023,19(4): 1152-1163.
|
| 14 |
Sachdev PS, Brodaty H, Valenzuela MJ, et al.The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients [J].Neurology, 2004, 62(6): 912-919.
|
| 15 |
Akinyemi RO, Owolabi MO, Ihara M, et al.Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa [J].Brain Res Bull, 2019, 145: 97-108.
|
| 16 |
Uemura MT, Maki T, Ihara M, et al.Brain microvascular pericytes in vascular cognitive impairment and dementia [J].Front Aging Neurosci,2020, 14: 12: 80.
|
| 17 |
Duncombe J, Kitamura A, Hase Y, et al.Chronic cerebral hypoperfusion:a key mechanism leading to vascular cognitive impairment and dementia.Closing the translational gap between rodent models and human vascular cognitive impairment and dementia [J].Clin Sci (Lond),2017, 131(19): 2451-2468.
|
| 18 |
Kalaria RN.Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease [J].Acta Neuropathol, 2016, 131(5): 659-685.
|
| 19 |
Alber J, Alladi S, Bae HJ, et al.White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID):knowledge gaps and opportunities [J].Alzheimers Dement (N Y),2019, 9(5): 107-117.
|
| 20 |
Kliper E, Ben Assayag E, Tarrasch R, et al.Cognitive state following stroke: the predominant role of preexisting white matter lesions [J].PLoS One, 2014, 9(8): e105461.
|
| 21 |
Kang HJ, Stewart R, Park MS, et al.White matter hyperintensities and functional outcomes at 2 weeks and 1 year after stroke [J].Cerebrovasc Dis, 2013, 35(2): 138-145.
|
| 22 |
Brier MR, Blazey T, Raichle ME, et al.Increased white matter glycolysis in humans with cerebral small vessel disease [J].Nat Aging,2022, 2(11): 991-999.
|
| 23 |
Burton EJ, Kenny RA, O'Brien J, et al.White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients [J].Stroke, 2004, 35(6):1270-1275.
|
| 24 |
Hainsworth AH.White matter lesions in cerebral small vessel disease:underperfusion or leaky vessels? [J].Neurology, 2019, 92(15):687-688.
|
| 25 |
Jokinen H, Kalska H, Mantyla R, et al.White matter hyperintensities as a predictor of neuropsychological deficits post-stroke [J].J Neurol Neurosurg Psychiatry, 2005, 76(9): 1229-1233.
|
| 26 |
Yuzkan S, Balsak S, Cinkir U, et al.Multiple sclerosis versus cerebral small vessel disease in MRI: a practical approach using qualitative and quantitative signal intensity differences in white matter lesions [J].Acta Radiol, 2023, 2: 2841851231155608.
|
| 27 |
Firbank MJ, Burton EJ, Barber R, et al.Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors [J].Neurobiol Aging , 2007, 28(11): 1664-1669.
|
| 28 |
Wu X, Klomparens K, Chen Z, et al.Different patterns of white matter lesions among patent foramen ovale, atherosclerotic cerebral small vessel disease and cerebral venous thrombosis [J].J Thromb Thrombolysis, 2022, 53(4): 911-925.
|
| 29 |
Wardlaw JM, Smith EE, Biessels GJ, et al.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J].Lancet Neurol, 2013, 12(8): 822-838.
|
| 30 |
Wardlaw JM, Smith C, Dichgans M.Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging [J].Lancet Neurol,2013, 12(5): 483-497.
|
| 31 |
Makin SD, Turpin S, Dennis MS, et al.Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence,prevalence and comparison with other stroke subtypes [J].J Neurol Neurosurg Psychiatry, 2013, 84(8): 893-900.
|
| 32 |
Chen CF, Lan SH, Khor GT, et al.Cognitive dysfunction after acute lacunar infarct [J].Kaohsiung J Med Sci, 2005, 21(6): 267-271.
|
| 33 |
Edwards JD, Jacova C, Sepehry AA, et al.A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke [J].Neurology, 2013, 80(3): 315-322.
|
| 34 |
Blanco-Rojas L, Arboix A, Canovas D, et al.Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study [J].BMC Neurol, 2013, 16(13): 203.
|
| 35 |
Wardlaw JM, Woodhouse LJ, Mhlanga II, et al; Lacunar Intervention Trial-2 (LACI-2) Investigator Group.Isosorbide Mononitrate and Cilostazol treatment in patients with symptomatic cerebral small vessel disease: the lacunar intervention trial-2 (LACI-2) randomized clinical trial [J].JAMA Neurol, 2023, 80(7): 682-692.
|
| 36 |
Poels MM, Ikram MA, van der Lugt A, et al.Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study [J].Neurology, 2012, 78(5): 326-333.
|
| 37 |
Cordonnier C, Al-Shahi Salman R, Wardlaw J.Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting [J].Brain, 2007, 130(Pt 8): 1988-2003.
|
| 38 |
Werring DJ, Frazer DW, Coward LJ, et al.Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI [J].Brain, 2004, 127(Pt 10): 2265-2275.
|
| 39 |
Gregoire SM, Smith K, Jager HR, et al.Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients [J].Cerebrovasc Dis, 2012, 33(5): 430-435.
|
| 40 |
Patel N, Banahan C, Janus J, et al.Perioperative cerebral microbleeds after adult cardiac surgery [J].Stroke, 2019, 50(2): 336-343.
|
| 41 |
Tang WK, Chen YK, Lu JY, et al.Absence of cerebral microbleeds predicts reversion of vascular 'cognitive impairment no dementia' in stroke [J].Int J Stroke, 2011, 6(6): 498-505.
|
| 42 |
Miwa K, Koga M, Inoue M, et al.Cerebral microbleeds development after stroke thrombolysis: a secondary analysis of the THAWS randomized clinical trial [J].Int J Stroke, 2022, 17(6): 628-636.
|
| 43 |
Smith EE, Schneider JA, Wardlaw JM, et al.Cerebral microinfarcts:the invisible lesions [J].Lancet Neurol, 2012, 11(3): 272-282.
|
| 44 |
Wang M, Ding F, Deng S, et al.Focal solute trapping and global glymphatic pathway impairment in a murine model of multiple microinfarcts [J].J Neurosci, 2017, 37(11): 2870-2877.
|
| 45 |
Louveau A, Smirnov I, Keyes TJ, et al.Structural and functional features of central nervous system lymphatic vessels [J].Nature, 2015,523(7560): 337-341.
|
| 46 |
Launer LJ, Hughes TM, White LR.Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study [J].Ann Neurol, 2011, 70(5): 774-780.
|
| 47 |
Marc G, Dubas F.Cerebral microangiopathies [J].Psychol Neuropsychiatr Vieil, 2005, 3(2): 83-88.
|
| 48 |
Zhang L, Biessels GJ, Hilal S, et al.Cerebral microinfarcts affect brain structural network topology in cognitively impaired patients [J].J Cereb Blood Flow Metab, 2021, 41(1): 105-115.
|
| 49 |
Brown R, Benveniste H, Black SE, et al.Understanding the role of the perivascular space in cerebral small vessel disease [J].Cardiovasc Res,2018, 114(11): 1462-1473.
|
| 50 |
Benveniste H, Nedergaard M.Cerebral small vessel disease: A glymphopathy? [J].Curr Opin Neurobiol, 2022, 72: 15-21.
|
| 51 |
Yu L, Hu X, Li H, et al.Perivascular spaces, glymphatic system and MR [J].Front Neurol, 2022, 13: 844938.
|
| 52 |
Jiang R, Chen S, Shen Y, et al.Higher levels of lipoprotein associated phospholipase A2 is associated with increased prevalence of cognitive impairment: the APAC Study [J].Sci Rep, 2016, 9: 6: 33073.
|
| 53 |
Libby P, Ridker PM, Hansson GK.Progress and challenges in translating the biology of atherosclerosis [J].Nature, 2011, 473(7347):317-325.
|
| 54 |
Walker KA, Power MC, Hoogeveen RC, et al.Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: the atherosclerosis risk in communities study [J].Stroke,2017, 48(12): 3196-3202.
|
| 55 |
Jalal FY, Yang Y, Thompson J, et al.Myelin loss associated with neuroinflammation in hypertensive rats [J].Stroke, 2012, 43(4):1115-1122.
|
| 56 |
Jalal FY, Yang Y, Thompson JF, et al.Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP [J].J Cereb Blood Flow Metab, 2015, 35(7): 1145-1153.
|
| 57 |
Liu L, Zhang X, Jiang N, et al.Plasma lipoprotein-associated phospholipase A2 affects cognitive impairment in patients with cerebral microbleeds [J].Neuropsychiatr Dis Treat, 2023, 19:635-646.
|
| 58 |
Dhamoon MS, Cheung YK, Moon YP, et al.Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories [J].PLoS one, 2019, 14(4): e0214784.
|
| 59 |
Dhana A, DeCarli C, Dhana K, et al.White matter hyperintensity,neurofilament light chain, and cognitive decline [J].Ann Clin Transl Neurol, 2023,10(3): 321-327.
|
| 60 |
Li BH, Du BY, Gu ZS, et al.Correlations among peripheral blood markers, white matter hyperintensity, and cognitive function in patients with non-disabling ischemic cerebrovascular events [J].Front Aging Neurosci, 2022, 14: 1023195.
|